Royce & Associates LP Abiomed Inc Transaction History

Royce & Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $709,060 - $899,500	-2,000 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$278.07 - $446.21 $2.22 Million - $3.57 Million	-8,000 Reduced 80.0%	2,000 $818,000
Q4 2017 Feb 09, 2018	SELL	$168.78 - $199.74 $1.69 Million - $2 Million	-10,000 Reduced 50.0%	10,000 $1.87 Million
Q2 2017 Aug 07, 2017	BUY	N/A	20,000	20,000 $2.87 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.